Press release
Competitive Landscape: Key Leaders and New Entrants in the Pharmaceutical Lipid-Based Excipients Market
Pharmaceutical Lipid-Based Excipients Market
Projected Market Value and Growth Trajectory of the Pharmaceutical Lipid-Based Excipients Market
The pharmaceutical lipid-based excipients market is anticipated to reach a valuation of $2.17 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This upward trend is driven by rising demand for sophisticated drug delivery systems, broader adoption of mRNA and gene therapies, an expanding portfolio of drugs with poor water solubility, and a heightened focus on personalized medicine. Supportive regulations and increased investment in biopharmaceutical manufacturing infrastructure also contribute to this growth. Key developments expected during the forecast period include innovations in lipid nanoparticle delivery methods, enhanced solubility solutions, sustainable lipid sourcing, scalable manufacturing processes, and the application of lipid-based excipients in both oral and injectable drug formulations.
Download a free sample of the pharmaceutical lipid-based excipients market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24374&type=smp
Primary Companies Leading the Pharmaceutical Lipid-Based Excipients Market
The market is shaped by a range of prominent players including Cargill Incorporated, BASF SE, Merck KGaA, FUJIFILM Corporation, Evonik Industries AG, DuPont de Nemours Inc., Stepan Company, Croda International, Ashland Corporation, NOF CORPORATION, CordenPharma, SEPPIC, Nippon Fine Chemical Co. Ltd., Cayman Chemical, ABITEC Corporation, Creative Biolabs, IOI Oleo GmbH, Lipoid, RuixiBiotechCo.Ltd, and Biosynth.
In June 2024, CordenPharma, headquartered in Switzerland, formed a partnership with Certest Biotec S.L., a biotechnology firm based in Spain. This collaboration is designed to incorporate Certest's proprietary ionizable lipids into CordenPharma's lipid nanoparticle (LNP) formulation services, thereby enhancing RNA/DNA therapeutic development through combined expertise in lipid innovation, manufacturing, and regulatory affairs.
Emerging Trends Highlighting Growth in the Pharmaceutical Lipid-Based Excipients Market
Industry leaders are investing strategically to foster innovation and improve drug delivery capabilities. A notable example occurred in November 2024 when Gattefossé SAS, a French chemical manufacturer, inaugurated a state-of-the-art Technical Center of Excellence in Mumbai. This facility aims to support the expanding pharmaceutical market in India by providing specialized laboratories and tailored support focused on excipient innovation, including bioavailability improvements, sustained release, and topical formulation advancements. The center is equipped with pharmaceutical and personal care application labs, designed to promote collaboration and innovation while strengthening the company's footprint in the Asia-Pacific region.
View the full pharmaceutical lipid-based excipients market report:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-lipid-based-excipients-global-market-report
Detailed Segmentation Driving the Pharmaceutical Lipid-Based Excipients Market
The pharmaceutical lipid-based excipients market is categorized into several key segments:
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC (Glyceryl Mono/Diesters of C16/C18), Hard Fats, Medium Chain Triglycerides, Lecithin and Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, and Other Excipient Types.
2) By Product Applications: Oral Formulations, Parenteral, Topical, Ophthalmic, Suppositories, and Other Applications.
3) By Disease Application: Cardiovascular, Neurological, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, and Other Disease Categories.
4) By Age Group: Pediatric (0-18 years), Adult (19-64 years), and Geriatric (65+ years).
5) By End Users: Pharmaceutical Manufacturers, Contract Development and Manufacturing Organizations, and Other Users.
Further Subcategories of Excipient Types
Oils include soybean, olive, palm, sunflower, and other oils. Hydrogenated vegetable oils cover hydrogenated soybean, palm, cottonseed, and other variants. GMCC is broken down into glyceryl monostearate, distearate, monopalmitate, and others. Hard fats consist of hydrogenated castor oil, palm kernel oil, coconut oil, and additional types. Medium Chain Triglycerides (MCTs) include capric, caprylic, caprylic-capric triglycerides, among others. Lecithins and phospholipids encompass soy lecithin, egg lecithin, phosphatidylcholine, phosphatidylserine, and other forms. Sodium oleate is divided into pharmaceutical, food, and industrial grades. Capri-caprylic mono/diglycerides include monoglycerides and diglycerides. Other excipient types cover sucrose esters, fatty acid esters, PEGylated lipids, and miscellaneous lipids.
This detailed segmentation provides a comprehensive framework for understanding the various components driving growth and innovation within the pharmaceutical lipid-based excipients market.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Key Leaders and New Entrants in the Pharmaceutical Lipid-Based Excipients Market here
News-ID: 4318638 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
